UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Astellas Korea names Masujima Keita as new CEO
by Lee Han-soo
2019-04-01 11:02
Bayer reports 8th-consecutive-year growth in Asia-Pacific
by Lee Han-soo
2019-04-01 11:02
LG Chem, Sprint to co-develop NASH treatment
by Lee Han-soo
2019-04-01 11:01
‘Expanded reimbursement for Prolia to give more options to osteoporosis patients’
by Lee Han-soo
2019-03-29 18:32
Phase-3 trials of Huntington’s chorea treatment approved
by Lee Hye-seon
2019-03-29 17:24
라인
Il-yang to research Parkinson’s disease in Europe
by Lee Han-soo
2019-03-28 16:28
Allergan to resume marketing of macular edema treatment
by Lee Han-soo
2019-03-27 16:55
JW Life Science wins nod for 3rd-generation nutrient infusion in Europe
by Jeong Sae-im
2019-03-27 16:16
FDA OKs CrystalGenomics’ P1 trial for leukemia treatment
by Lee Han-soo
2019-03-27 15:58
‘Remimazolam has fewer side effects than propofol’
by Jeong Sae-im
2019-03-27 15:05
라인
CJ Healthcare releases P3 trial results for gastroesophageal reflux treatment
by Lee Han-soo
2019-03-27 14:52
AstraZeneca to launch Imfinzi in Korea next month
by Lee Han-soo
2019-03-27 14:52
Hanlim Pharm seeks to expand HL301’s indication for radiation pneumonitis
by Lee Hye-seon
2019-03-26 15:57
Doctors outrageous over MSD Korea’s recordings of their talks
by Park Gi-taek
2019-03-25 16:05
Daewoong releases P3 trial results for Nabota
by Lee Han-soo
2019-03-25 15:01
라인
Regulator OKs immunotherapies developed by multinational pharma companies
by Lee Han-soo
2019-03-25 11:28
Otsuka Korea CEO receives presidential citation
by Lee Han-soo
2019-03-22 16:52
Setback in search for Alzheimer’s drug: Biogen halts phase-3 aducanumab trials
by Kim Yun-mi
2019-03-22 15:50
Eubiologics gets nod to test botulinum toxin in phase-1 study
by Lee Hye-seon
2019-03-22 15:28
‘MSD Korea excessively monitors workers, collects client info without consent’
by Jeong Sae-im
2019-03-22 13:49
-
이전
41
42
43
44
45
46
47
48
49
50
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top